Nutanix stock saw a welcome improvement to its Relative Strength (RS) Rating on Thursday, with an upgrade from 72 to 81. IBD's unique RS Rating measures market leadership by using a 1 (worst) to 99 (best) score that indicates how a stock's price action over the trailing 52 weeks matches up against that of all other stocks.